Analysis of the association between prior chemotherapy regimens and outcomes of subsequent anti-PD-(L)1 monotherapy in advanced non-small cell lung cancer

BACKGROUND: Immune checkpoint inhibitor (ICI) monotherapy targeting PD-1/PD-L1 has been a prominent option for the patients with advanced non-small cell lung cancer (NSCLC), which is now commonly used in second- or later-line settings after the failure of conventional chemotherapy. Chemotherapy can...

Full description

Saved in:
Bibliographic Details
Published in:Transl Lung Cancer Res
Main Authors: Gao, Guanghui, Jia, Keyi, Zhao, Sha, Li, Xuefei, Zhao, Chao, Jiang, Tao, Su, Chunxia, Ren, Shengxiang, Zhou, Fei, Zhou, Caicun
Format: Artigo
Language:Inglês
Published: AME Publishing Company 2019
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6976343/
https://ncbi.nlm.nih.gov/pubmed/32010570
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2019.11.25
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items